RankAlpha logo
Back to Rankings

PYPD

PolyPidF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PYPD vs peer average
22/100
PYPD vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RLYB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $90.28M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRLYBRallybio
PYPD
PolyPid
RLYB
Rallybio
Grade
F
F
Momentum
19
88
Value
41
71
Sentiment
-
2
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs RLYB

PYPD / RLYB
Grade Position
Below peers
PYPD vs. peer average (F vs. C)
22/100
Momentum
19
RLYB
Value
41
RLYB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PYPD
1
RLYB
Rallybio Corp Common
F
20/100
Even
2
GANX
Gain Therapeutics Inc Common
C
60/100
-2
3
FBIO
Fortress Biotech Inc Common
A
100/100
-4
4
ICCC
ImmuCell Corp Common
D
40/100
-1
5
ALDX
Aldeyra Therapeutics Inc Common
B
80/100
-3
RLYB is the first peer returned for this comparison set.